VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
NMRA
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
NMRANeumora Therapeutics, Inc. Common Stock
$0.37$68M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksNMRAQuarterly Financials

Neumora Therapeutics, Inc. Common Stock (NMRA) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Neumora Therapeutics, Inc. Common Stock (NMRA) quarterly income statement — complete revenue, gross profit & net income history

Income StatementBalance SheetCash FlowRatios

NMRA Income Statement

Quarterly statement

NMRA Income Statement

Neumora Therapeutics, Inc. Common Stock (NMRA) annual income statement — 6-year revenue, gross profit & net income history

AnnualQuarterly
MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q2'22Q1'22Q4'21Q3'21
Sales/Revenue16K0000000000000000000
Revenue Growth %--------------------
Cost of Goods Sold8K08K05M000000166K00000000
COGS % of Revenue50%-------------------
Gross Profit8K0-8K0-5M000000-166K00000000
Gross Margin %50%-------------------
Gross Profit Growth %100.16%------100%------------
Operating Expenses33.41M42.19M52.86M58.48M52.7M54.04M70.94M62.92M76.65M63.82M60.07M49.93M56.86M42.06M39.17M30.72M31.31M43.24M26.55M178.13M
OpEx % of Revenue208806.25%-------------------
Selling, General & Admin10.79M12.91M14.27M13.81M12.18M15.32M18.79M17.01M16.02M15.19M14.32M11.07M15.26M9.29M9.68M7.2M7.79M8.09M7.64M6.66M
SG&A % of Revenue67468.75%-------------------
Research & Development22.61M29.28M38.6M44.67M40.52M38.72M52.15M45.91M60.63M48.63M45.76M38.86M41.6M32.77M29.48M23.52M23.53M35.15M18.91M171.47M
R&D % of Revenue141337.5%-------------------
Other Operating Expenses00000000000000000000
Operating Income-33.41M-42.19M-52.86M-58.48M-57.7M-54.04M-70.94M-62.92M-76.65M-63.82M-60.07M-50.1M-56.86M-42.06M-39.17M-30.72M-31.31M-43.24M-26.55M-178.13M
Operating Margin %-208806.25%-------------------
Operating Income Growth %42.1%21.93%25.48%7.06%24.72%15.33%-18.08%-25.59%-34.79%-51.73%-53.38%-63.1%--34.32%9.41%-15.71%---35.94%-
EBITDA-33.42M-42.18M-52.86M-58.47M-57.68M-54.02M-70.78M-62.77M-76.49M-63.66M-59.92M-49.93M-56.69M-41.89M-39.01M-30.57M-31.16M-43.09M-26.42M-177.98M
EBITDA Margin %-208900%-------------------
EBITDA Growth %42.05%21.91%25.32%6.84%24.6%15.14%-18.13%-25.7%-34.92%-51.97%-53.59%-63.34%--34.44%9.47%-15.73%---35.71%-
D&A (Non-Cash Add-back)-15K7K8K9K23K19K157K157K156K160K158K166K173K171K158K147K154K147K131K150K
EBIT0-42.18M-51.57M-57.41M-56.01M-52.71M-67.89M-58.82M-72.49M-58.58M-53.72M-108.46M-56.86M-42.06M-39.17M-30.72M-31.31M-43.24M-26.55M-178.13M
Net Interest Income0-885K-623K-701K938K1.81M3.07M4.09M4.21M5.27M6.37M5.65M3.84M3.56M3.57M2.29M784K86K00
Interest Income809K935K1.23M1.33M1.69M1.81M3.07M4.09M4.21M5.27M6.37M5.65M3.84M3.56M3.57M2.29M784K86K00
Interest Expense-9.18M1.82M1.85M2.04M747K000000000000000
Other Income/Expense-1.03M-892K-564K-970K945K1.33M3.05M4.1M4.15M5.25M6.35M-58.36M3.84M3.52M3.54M2.57M942K194K-422K103K
Pretax Income-34.44M-43.08M-53.43M-59.45M-56.76M-52.71M-67.89M-58.82M-72.49M-58.58M-53.72M-108.46M-53.03M-38.54M-35.63M-28.15M-30.37M-43.04M-26.97M-178.03M
Pretax Margin %-215243.75%-------------------
Income Tax1K030K0025K105K053K125K0268K00000000
Effective Tax Rate %-0%0%-0.06%0%0%-0.05%-0.15%0%-0.07%-0.21%0%-0.25%0%0%0%0%0%0%0%0%
Net Income-34.44M-43.08M-53.46M-59.45M-56.76M-52.73M-67.99M-58.82M-72.55M-58.7M-53.72M-108.73M-53.03M-38.54M-35.63M-28.15M-30.37M-43.04M-26.97M-178.03M
Net Margin %-215250%-------------------
Net Income Growth %39.32%18.3%21.38%-1.07%21.77%10.17%-26.57%45.9%-36.81%-52.3%-50.8%-286.31%--26.9%17.23%-4.36%---34.86%-
Net Income (Continuing)0-43.08M-53.46M-59.45M-56.76M-52.73M-67.99M-58.82M-72.55M-58.7M-53.72M-108.73M-53.03M-38.54M-35.63M-28.15M-30.37M-43.04M-26.97M-178.03M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.18-0.23-0.30-0.35-0.35-0.33-0.42-0.37-0.45-0.37-0.34-0.68-0.34-0.25-0.23-0.19-0.20-0.28-0.18-1.17
EPS Growth %48.57%30.3%28.57%5.41%22.22%10.81%-23.53%45.59%-32.35%-48%-47.83%-257.89%--25%17.86%-5.56%---38.46%-
EPS (Basic)-0.18-0.23-0.30-0.35-0.35-0.33-0.42-0.37-0.45-0.37-0.34-0.68-0.34-0.25-0.23-0.19-0.20-0.28-0.18-1.17
Diluted Shares Outstanding184.32M185.16M179.87M163.39M161.84M161.69M161.45M160.98M159.58M158.98M157.94M158.83M155.39M151.95M151.95M151.95M151.95M151.95M151.95M151.95M
Basic Shares Outstanding184.32M185.16M179.87M163.39M161.84M161.69M161.45M160.98M159.58M158.98M157.94M158.83M155.39M151.95M151.95M151.95M151.95M151.95M151.95M151.95M
Dividend Payout Ratio--------------------